BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells

Nature Immunology

Volumn 3, Issue 10, 2002, Pages 958-965

  Claudio, Estefania ^a   Brown, Keith ^a   Park, Sun ^a   Wang, Hongshan ^a   Siebenlist, Ulrich ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN INHIBITOR; PROTEIN KINASE; PROTEIN P100; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CATALYSIS; CELL MATURATION; COMPLEX FORMATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SPLEEN CELL;

ANIMALS; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SURVIVAL; I-KAPPA B KINASE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; NF-KAPPA B P52 SUBUNIT; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036794398     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni842     Document Type: Article

References (34)

1. Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle Cell 109 (Suppl) 81-96 (2002).
2. Caamano, J. & Hunter C.A. NF-κB family of transcription factors: central regulators of innate and adaptive immune functions Clin. Mirobiol. Rev. 15, 414-429 (2002).
3. Franzoso, G. et al. Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture J. Exp. Med. 187, 147-159 (1998).
4. Caamano J. H. et al. Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses J. Exp. Med. 187, 185-196 (1998).
5. Gugasyan, R. et al. Rel/NF-κB transcription factors: key mediators of B-cell activation Immunol. Rev. 176, 134-140 (2000).
6. Franzoso, G. et al. Requirement for NF-κB in osteoclast and B cell differentiation Genes Dev. 11, 3482-3496 (1997).
7. Iotsova, V. et al. Osteopetrosis in mice lacking NF-κB1 and NF-κB2 Nature Med 3, 1285-1289 (1997).
8. Mackay, F. & Mackay, C. R. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol. 23, 113-115 (2002).
9. Rolink, A. G. & Melchers, F. BAFFled B cells survive and thrive: roles of BAFF in B-cell development Curr. Opin. Immunol. 14, 266-275 (2002).
10. Do, R. K. & Chen-Kiang S. Mechanism of BLyS action in B cell immunity. Cytokine Growth Factor Rev. 13, 19-25 (2002).
11. Mackay, F. & Browning, J. L. BAFF: A fundamental survival factor for B cells. Nature Rev. Immunol. 2, 465-475 (2002).
12. Thompson, J. S. et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293, 2108-2111 (2001).
13. Khare, S. D. et al. Severe B cell hyperplasia and autoimmune disease in TALL-I transgenic mice. Proc. Natl. Acad. Sci. USA 97, 3370-3375 (2000).
14. Dorner, T. & Putterman C. B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus. Arthritis Res. 3, 197-199 (2001).
15. Groom, J. et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest 109, 59-68 (2002).
16. Schiemann, B. et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293, 2111-2114 (2001).
17. Loder, F. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190, 75-89 (1999).
18. Khan, W. N. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase. Immunal. Res. 23, 147-156 (2001).
19. Grossmann, M. et al. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J. 19, 6351-6360 (2000).
20. Rolink, A. G. et al. Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J. Exp. Med. 191, 23-32 (2000).
21. Su, T.T. & Rawlings, D.J. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J. Immunol. 168, 2101-2110 (2002).
22. Cariappa, A. et al. Nuclear factor κB is required for the development of marginal zone B lymphocytes. J. Exp. Med. 192, 1175-1182 (2000).
23. Kanno, T. et al. Human T-cell leukemia virus type I Tax-protein-mediated activation of NF-κB from p100 (NF-κB2)-inhibited cytoplasmic reservoirs. Proc. Natl. Acad. Sci. USA 91, 12634-42638 (1994).
24. Xiao, G. et al. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell 7, 401-409 (2001).
25. Senftleben, U. et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293, 1495-1499 (2001).
26. Yamada, T. et al. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-κB-inducing kinase. J. Immunol. 165, 804-812 (2000).
27. Kaisho, T. et al. IκB kinase α is essential for mature B cell development and function. J. Exp. Med. 193, 417-426 (2001).
28. Do, R. K. et al. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192, 953-964 (2000).
29. Solan, N.J. et al. RelB cellular regulation and transcriptional activity are regulated by p100. J. Biol. Chem. 277, 1405-4418 (2002).
30. Yamaoka, S. et al. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93, 1231-1240 (1998).
31. Batten, M. et al. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192, 1453-1465 (2000).
32. Ellinger-Ziegelbauer, H. et al. Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by an inducible mitogen-activated protein Kinase/ERK kinase kinase 3 (MEKK) derivative. J. Biol. Chem. 272, 2668-2674 (1997).
33. Dignam, J. D. et al. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489 (1983).
34. Krappmann, D. et al. Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor 1κB α in vivo. EMBO J. 15, 6716-6726 (1996).